Lazard Asset Management LLC Buys 918 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS)

Lazard Asset Management LLC boosted its stake in OrthoPediatrics Corp. (NASDAQ:KIDSGet Rating) by 75.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,127 shares of the company’s stock after purchasing an additional 918 shares during the period. Lazard Asset Management LLC’s holdings in OrthoPediatrics were worth $91,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. Brown Advisory Inc. grew its position in OrthoPediatrics by 25.2% in the 2nd quarter. Brown Advisory Inc. now owns 1,503,287 shares of the company’s stock worth $64,961,000 after purchasing an additional 302,186 shares during the period. Riverbridge Partners LLC grew its position in OrthoPediatrics by 0.3% in the 2nd quarter. Riverbridge Partners LLC now owns 1,157,148 shares of the company’s stock worth $49,931,000 after purchasing an additional 4,002 shares during the period. Invesco Ltd. grew its position in OrthoPediatrics by 9.3% in the 1st quarter. Invesco Ltd. now owns 455,486 shares of the company’s stock worth $24,593,000 after purchasing an additional 38,638 shares during the period. New York State Common Retirement Fund grew its position in OrthoPediatrics by 13.5% in the 1st quarter. New York State Common Retirement Fund now owns 435,803 shares of the company’s stock worth $23,529,000 after purchasing an additional 51,924 shares during the period. Finally, Granahan Investment Management LLC grew its position in OrthoPediatrics by 44.2% in the 1st quarter. Granahan Investment Management LLC now owns 374,867 shares of the company’s stock worth $20,239,000 after purchasing an additional 114,844 shares during the period.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. Piper Sandler cut their target price on shares of OrthoPediatrics from $58.00 to $52.00 in a research report on Tuesday, November 1st. Truist Financial cut their price objective on shares of OrthoPediatrics from $66.00 to $52.00 and set a “buy” rating for the company in a research report on Monday, October 17th. BTIG Research boosted their price objective on shares of OrthoPediatrics to $62.00 in a research report on Tuesday, August 9th. Needham & Company LLC cut their price objective on shares of OrthoPediatrics from $59.00 to $50.00 and set a “buy” rating for the company in a research report on Tuesday, November 1st. Finally, JMP Securities cut their price objective on shares of OrthoPediatrics from $70.00 to $60.00 and set a “market outperform” rating for the company in a research report on Wednesday, November 2nd. Four analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $54.33.

OrthoPediatrics Stock Performance

Shares of OrthoPediatrics stock opened at $44.01 on Thursday. The company has a market capitalization of $1.01 billion, a P/E ratio of 115.82 and a beta of 0.79. The company has a fifty day moving average of $43.99 and a 200 day moving average of $45.74. OrthoPediatrics Corp. has a fifty-two week low of $36.36 and a fifty-two week high of $62.61.

OrthoPediatrics Profile

(Get Rating)

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

Featured Stories

Want to see what other hedge funds are holding KIDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OrthoPediatrics Corp. (NASDAQ:KIDSGet Rating).

Institutional Ownership by Quarter for OrthoPediatrics (NASDAQ:KIDS)

Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.